Viewing StudyNCT02988817



Ignite Creation Date: 2024-05-06 @ 9:26 AM
Last Modification Date: 2024-10-26 @ 12:14 PM
Study NCT ID: NCT02988817
Status: COMPLETED
Last Update Posted: 2023-08-01
First Post: 2016-12-01

Brief Title: Enapotamab Vedotin HuMax-AXL-ADC Safety Study in Patients With Solid Tumors
Sponsor: Genmab
Organization: Genmab

Organization Data

Organization: Genmab
Class: INDUSTRY
Study ID: GCT1021-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Genmab
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators